CD44 expression and hyaluronic acid binding of malignant glioma cells

Clinical and Experimental Metastasis

Volumn 17, Issue 1, 1999, Pages 71-76

  Knüpfer, Matthias M ^a,d   Poppenborg, H ^a   Hotfilder, M ^b   Kuhnel K ^a   Wolff, J E A ^b,c   Domula, M ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Cell culture; Extracellular matrix; Hyaluronidase; Tumor invasion; Tumor adhesion

Indexed keywords

BOVINE SERUM ALBUMIN; GLYCOSAMINOGLYCAN; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; FLUORESCENCE; GLIOMA CELL; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING;

ANIMALS; ANTIGENS, CD44; ANTIGENS, NEOPLASM; CELL ADHESION; GLIOMA; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MALE; RATS; TESTIS; TUMOR CELLS, CULTURED;

EID: 0032983573     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kim TS, Halliday AL, Hedley-Whyte ET, Convery K. Correlates of survival and Daumas- Duport grading system for astrocytomas. J Neurosurg 1991; 74: 27-37.
2. Pilkington GJ. Tumour cell migration in the central nervous system. Brain Pathol 1994; 4: 157-66.
3. Rutka JT, Apodaca G, Stern R, Rosenblum M. The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 1988; 69: 155-70.
4. Venstrom KA, Reichard LF. Extracellular matrix 2: role of extracellular matrix molecules and their receptors in the nervous system. FASEB J 1993; 7: 996-1003.
5. Bignami A, Hosley M, Dahl D. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat Embryol 1993; 188: 419-33.
6. Bignami A, Asher R. Some observations on the localization of hyaluronic acid in adult, newborn and embryonal rat brain. Int J Devl Neurosci 1992; 10: 45-57.
7. De Clerck YA, Shimada H, Gonzales-Gomez I, Raffel C. Tumoral invasion in the central nervous system. J Neurooncol 1994; 18: 111-21.
8. Merzak A, Koocheckpour S, Pilkington GJ. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 1994; 54: 3988-92.
9. Radotra B, McCormick D. Glioma invasion in vitro is mediated by CD44-Hyaluronan interactions. J Pathol 1997; 181: 434-8.
10. Pilkington GJ. The role of extracellular matrix in neoplastic glial invasion of the nervous system. Braz J Med Biol Res 1996; 29: 1159-72.
11. Knüpfer MM, Poppenborg H, Hotfilder M et al. Hyaluronic acid binding capacity of malignant glioma cells. Anticancer Res 1998; 18: 353-6.
12. Tung JS, Mark GE, Hollis GF. A microplate assay for hyaluronidase and hyaluronidase inhibitors. Anal Biochem 1994; 223: 149-52.
13. Hansen M, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measure cell growth/cell kill. J Immunol Methods 1991; 119: 203-10.
14. Asher R, Bignami A. Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 1992; 203: 80-90.
15. Sakai H, Nalashima S, Shin-ichi Y et al. Suppressed expression of CD44 variant isoforms during human glioma A172 cell differentiation by cyclic AMP. Neurosci Lett 1996; 210: 189-92.
16. Li H, Hamou MF, de-Tribolet N, Jaufeerally R et al. Variant CD44 adhesion molecules are expressed in human brainmetastases but not in glioblastomas. Cancer Res 1993; 53: 5345-9.
17. Eibl RH, Pietsch T, Moll J et al. Expression of variant CD44 epitopes in human astrocytic brain tumors. J Neurooncol 1995; 26: 165-70.
18. Kaaijk P, Troost D, Morsink F et al. Expression of CD44 splice variants in human primary brain tumors. J Neurooncol 1995; 26: 185-90.
19. Aruffo A, Stamenkovic I, Melnick M et al. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
20. Lesley J, Hyman R. CD44 structure and function. Front Biosci 1998; 3: D616-D330.
21. Frank S, Rihs HP, Stocker W et al. Combined detection of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry in primary human brain tumors and brain metastasis. Biochem Biophys Res Commun 1996; 222: 794-801.
22. Catterall JB, Gardner MJ, Jones LM, Turner GA. Binding of ovarian cancer cells to immmobilized hyaluronic acid. Glycoconj J 1997; 14: 647-9.
23. Lesley J, Hyman R, English N et al. CD44 in inflammation and metastasis. Glycoconj J 1997; 14: 611-22.
24. Skelton TP, Zeng C, Nocks A et al. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding hyaluronan. J Cell Biol 1998; 140: 431-46.
25. Zheng Z, Cummings R, Pummill P, Kincade P. Growth as a solid tumor or reduced glucose concentrations in culture reversible induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells. J Clin Invest 1997; 100: 1217-29.
26. Yu Q, Toole BP, Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997; 186: 1985-96.
27. Lokeshwar VB, Fregien N, Bourguignon LYW. Ankyrin-binding Domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol 1994; 126: 1099-109.
28. Zheng Z, Katoh S. Qi H et al. Monoclonal antibodies and their influence on hyaluronan recognition. J Cell Biol 1995; 130: 485-95.
29. Delpech B, Maingonnat C, Girard N. Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma. Eur J Cancer 1993; 29: 1012-17.
30. Hall CL, Turley EA. Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis. J Neurooncol 1995; 26: 221-9.
31. Baumgartner G, Horaczek A, Grunert P et al. Hyaluronidase als Zusatz zur zytostatischen Chemotherapie bei Glioblastomen. Onkologie 1987; 10: 100-3.